Sarcopenia and sarcopenic obesity in cardiovascular disease: a comprehensive review
- 1 August 2025
- journal article
- Published by Wolters Kluwer Health in Singapore Medical Journal
Abstract
Sarcopenia is the loss of muscle strength, mass and function. It is often exacerbated by chronic comorbidities such as cardiovascular diseases (CVDs). There is a bidirectional relationship between sarcopenia and CVD. Sarcopenia can lead to increased adiposity, insulin resistance and chronic inflammation, predisposing adults to developing cardiovascular events. Chronic inflammation and decreased physical activity observed in cardiac patients can lead to accelerated muscle loss and the development of sarcopenia. Sarcopenia is linked to faster CVD progression, higher mortality and reduced quality of life. The co-occurrence of obesity with sarcopenia is termed sarcopenic obesity (SO). This condition is associated with worse outcomes than either condition individually. Early detection is crucial, as interventions can slow or reverse sarcopenia and improve cardiovascular outcomes. This review summarises evidence on the interplay between CVD and sarcopenia, discusses diagnostic approaches and management strategies, and identifies knowledge gaps for future research.Keywords
This publication has 87 references indexed in Scilit:
- Weak Grip Strength Predicts Higher Unplanned Healthcare Utilization Among Patients with Heart FailureESC Heart Failure, 2023
- Handgrip strength and the prognosis of patients with heart failure: A meta‐analysisClinical Cardiology, 2023
- A more accurate method to estimate muscle mass: A new estimation equationJournal of Cachexia, Sarcopenia and Muscle, 2023
- Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomographyObesity, 2023
- Sarcopenia and cardiovascular diseases: A systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2023
- Pathogenesis of sarcopenia and the relationship with fat mass: descriptive reviewJournal of Cachexia, Sarcopenia and Muscle, 2022
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2021
- Sarcopenia in Heart Failure: A Systematic Review and Meta-AnalysisESC Heart Failure, 2021
- Mid‐adulthood cardiometabolic risk factor profiles of sarcopenic obesityObesity, 2016
- Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weaknessBiogerontology, 2008